# Jiangsu Anbison Pharmaceutical Co., Ltd. – FDA Inspection, Aug 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-anbison-pharmaceutical-co-ltd/d5e3c0b4-a844-438e-bf0d-a5fa8d06842a
Source feed: FDA_Inspections

> FDA inspection 1220343 of Jiangsu Anbison Pharmaceutical Co., Ltd., August 18, 2023. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220343
- Company Name: Jiangsu Anbison Pharmaceutical Co., Ltd.
- Inspection Date: 2023-08-18
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1246817 - 2024-07-16](https://www.keypedia.com/records/fda_inspections/jiangsu-anbison-pharmaceutical-co-ltd/a3035420-47a3-4e76-9feb-4c3f8faa0583)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)

Company: https://www.keypedia.com/companies/jiangsu-anbison-pharmaceutical-co-ltd/f9324a6c-1ec8-40eb-8148-73c13ea386df

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
